NYSE:MDT 20 August 2025

Intuitive Surgical (NASDAQ:ISRG) slides 6%; HCA surgery slowdown sharpens Q2 valuation test

Intuitive Surgical, Inc. sank 6.2% on Tuesday, on the same day HCA Healthcare, Inc. disclosed falling surgical volumes, creating an unusually timely demand test before the robotic-surgery maker’s second-quarter report. The stock’s valuation of 46.4 times trailing earnings leaves little room for a soft utilization number.

14 July 2026

NASDAQ:ISRG·NYSE:HCA·NYSE:MDT·NYSE:SYK·Stock Market

Medtronic shares get a lift after earnings, but another test is coming

Medtronic plc opened the week with gains from its earnings move still holding, though some shine has faded. Shares ended Friday at $81.67, slipping 0.32%. The stock hit an intraday low at $81.12 on the NYSE.

6 June 2026

Earnings Reports·NYSE:MDT·Stock Market

Medtronic Shares Near One-Year Lows as NYSE Open Looms After Friday Drop

Medtronic shares rise on earnings beat, 2027 risk still in view

Medtronic shares moved higher Wednesday as the company posted fiscal fourth-quarter revenue and adjusted profit above Wall Street targets, getting a lift from demand for its heart devices for complex cardiac procedures.

3 June 2026

Earnings Reports·NYSE:MDT

Medtronic Stock Jumps On Heart-Device Beat, But One 2027 Warning Hangs Over Rally

Medtronic plc shares jumped on Wednesday after the medical-device maker beat Wall Street’s fiscal fourth-quarter sales and profit estimates, helped by demand for heart devices used in complex cardiac procedures. The stock was recently up 5.1% at $77.52, outpacing a 0.6% rise in the iShares U.S. Medical Devices ETF.

3 June 2026

NYSE:MDT·Stock Market

Medtronic Shares Slip for the Week With Eyes on Wednesday for Direction

Medtronic plc starts the week under pressure after dropping for four straight sessions and finishing Friday at $73.81, with volume well above average. The move came even as the S&P 500 added 0.22%. Investors are now looking to the company's next comments and less to what the wider market is doing.

30 May 2026

NYSE:MDT·Stock Market

Medtronic Shares Near One-Year Lows as NYSE Open Looms After Friday Drop

Medtronic plc shares fell on Friday, tracking Wall Street’s pullback. The medical-device company stayed near a one-year low as the stock stayed weak heading into the weekend.

16 May 2026

NYSE:MDT·Stock Market

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Shares of Boston Scientific Corp closed Thursday roughly 1.6% lower at $92.33, having fluctuated between $91.48 and $94.25 during the session.

30 January 2026

Earnings Reports·NYSE:ABT·NYSE:BSX·NYSE:MDT·NYSE:PEN·NYSE:SYK·Stock Market

Medtronic stock slips as year-end trading thins and Fed minutes loom

Medtronic plc shares edged lower on Monday, closing down about 0.4% at $96.15, in a quiet start to the market’s final three sessions of the year. Yahoo Finance

30 December 2025

NYSE:MDT·Stock Market

Medtronic (MDT) Stock Update: Dividend Timing, MiniMed IPO Catalyst, and What Investors Should Watch Before Monday’s Open

Medtronic plc heads into the final full trading week of 2025 with U.S. equities closed for the weekend and futures reopening Sunday evening—setting the stage for Monday’s regular-session restart. The broader market backdrop remains constructive late in the year, with major indexes having pushed to record territory recently and investors still focused on “Santa rally” dynamics and year-end positioning. Investors+1

28 December 2025

Dividends·NYSE:MDT

Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

Medtronic plc heads into the weekend with investors balancing a quiet, year-end tape against several company-specific narratives that still matter for 2026: a freshly passed dividend record window, the planned separation of its diabetes business via the MiniMed IPO process, and continued focus on cardiovascular momentum that has helped drive the stock’s 2025 run.

27 December 2025

Dividends·IPO News·NYSE:MDT·Stock Market

Medtronic (MDT) Stock After Hours on Dec. 24, 2025: FDA Class I Recall Headline, Options Surge, Dividend Timing, and What to Watch Before Markets Reopen

Medtronic plc ended the holiday-shortened Christmas Eve session on Wednesday, December 24, 2025 essentially flat-to-lower, then ticked modestly higher in thin after-hours trading—exactly the kind of “quiet tape” investors often see when U.S. markets close early for the holiday. New York Stock Exchange+2Investor Relations | Medtronic+2

25 December 2025

NYSE:MDT

Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

As U.S. markets head into Monday’s open, Intuitive Surgical, Inc. is back in focus after a busy stretch of headlines spanning new FDA clearances, competitive pressure rising, and fresh Wall Street calls.

14 December 2025

NASDAQ:ISRG·NYSE:MDT

Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

As of the latest completed trading session, Medtronic’s NYSE‑listed shares closed at $101.36, with modest after‑hours trading around $101.31. StockAnalysis

7 December 2025

Dividend Investing·NYSE:MDT

Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

As of the close on 5 December 2025, Medtronic plc stock trades around $101.36–$101.39 per share, giving the medical device giant a market capitalization of roughly $130 billion, a P/E ratio near 27.4, and a dividend yield of about 2.8%. MarketBeat+2StockAnalysis+2

6 December 2025

Dividend Investing·NYSE:MDT

Medtronic (MDT) Stock Near 52‑Week High as Truist Hikes Target and Norges Bank Buys Big

Medtronic plc is back in the spotlight on 29 November 2025, with its stock trading close to record levels after a strong earnings beat, a fresh wave of analyst updates and sizeable moves from some of the world’s biggest institutional investors.

30 November 2025

NYSE:MDT·Stock Market

Medtronic Stock Today, November 26, 2025: MDT Hits Fresh 52‑Week High on Earnings Momentum and Analyst Upgrades

Medtronic plc’s share price is pushing to new 52‑week highs as investors digest last week’s strong Q2 FY26 results, a fresh SEC filing, renewed institutional buying and a wave of bullish analyst target hikes. Together, they are underpinning one of the strongest runs Medtronic stock has seen in years.

26 November 2025

Earnings Reports·NYSE:MDT·Stock Market

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic Stock Jumps Above $100 After Q2 FY26 Beat and Raised Outlook on 18 November 2025

Medtronic stock is in rally mode today, 18 November 2025, after the medical-device giant posted better‑than‑expected fiscal Q2 2026 results and raised its full‑year outlook, powered by booming demand for heart and diabetes technologies.

18 November 2025

Earnings Reports·NYSE:MDT·Stock Market

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic plc is back in the spotlight today after reporting stronger‑than‑expected results for the second quarter of fiscal 2026 and raising its full‑year outlook. The medical technology giant delivered solid revenue and earnings growth, highlighted powerful momentum in its cardiac ablation franchise, and signaled confidence in accelerating growth in the second half of the year. Medtronic News+1

18 November 2025

Earnings Reports·Healthcare Innovation·NYSE:MDT·Stock Market

Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Sources: Reuters, Politico, HealthLeaders, BioPharma Dive, FierceBiotech, Pharmaceutical Executive, Technology Networks, McGill University reuters.com reuters.com healthleadersmedia.com reuters.com fiercebiotech.com reuters.com reuters.com technologynetworks.com technologynetworks.com.

21 August 2025

NYSE:CRL·NYSE:LLY·NYSE:MDT·NYSE:NVO·NYSE:PFE·NYSE:TAK·Pharmaceuticals

Biotech Breakthroughs, Pharma Shakeups & Health Alerts – Global News Roundup (Aug 19–20, 2025)

Sources: Key information in this report is drawn from reputable industry and news outlets including Reuters reuters.com reuters.com, Fierce Biotech/Pharma fiercebiotech.com fiercebiotech.com, Endpoints News, STAT, and official statements from organizations like the FDA, EMA, WHO, and leading medical journals. For full details and additional context, please refer to the cited sources inline.

20 August 2025

ASX:CSL·Biotechnology·Health News·NYSE:MDT·Pharmaceuticals·XETRA:MRK

NYSE:MDT 20 August 2025 - 14 July 2026